Tuberculosis (TB) is a contagious airborne disease caused mainly by Mycobacterium tuberculosis, which infects one-fourth of the world’s population. With timely diagnosis and appropriate treatment, further spread of the disease can be prevented. WHO/Europe supports the implementation of the End TB Strategy and works with key international and national partners to support Member States in the WHO European Region to eliminate TB.Read more
Top storyDrug resistant strains could become the dominant form of TB in Europe: it’s time to end TB
If the current situation continues, the majority of tuberculosis (TB) patients in the next generation could be suffering from drug resistant forms of the disease. The latest WHO/European Centre for Disease Prevention and Control (ECDC) report, “Tuberculosis surveillance and monitoring in Europe 2019 (2017 data)”, shows that the European Region is struggling to make sufficient progress to finally end TB.
- Romania: tuberculosis patients to avoid unnecessary hospitalization
- European Laboratory Initiative on TB, HIV and Viral Hepatitis sets priorities for integrated testing and diagnosis in 2020–2021
- Time for integrated and people-centred services for HIV, TB and viral hepatitis
Call for applications
WHO/Europe seeks a maximum of 3 new members to join the European Laboratory Initiative (ELI) core group for 2019–2020.Deadline for application: 31 January 2020
PublicationsUnited Nations common position on ending HIV, TB and viral hepatitis through intersectoral collaboration (2018) More publications
Moscow DeclarationMoscow Declaration to End Tuberculosis: global commitment to scale up action
Health workers, aid workers and patients are making a difference in the fight against TB.More personal stories from the European Region
Video – Towards ending TB in the WHO European RegionMore videos
Data and statistics
If left untreated, each person with active TB infects, on average, this number of people every year.
More data and statistics